Michael J.O. Wakelam

Babraham Institute — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

75h-index20.9kcitations364works23.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Kinase Regulation and GTPase Signaling(75), Metabolomics and Mass Spectrometry Studies(41), Pancreatic function and diabetes(39), Metabolism, Diabetes, and Cancer(35), Cellular transport and secretion(32)

Publications364 total

Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards
Nature Communications·2024· 23 citedOpen Access
The wide world of non-mammalian phospholipase D enzymes
Advances in Biological Regulation·2023· 2 cited
Supplementary Figure 7 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 3 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 2 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 5 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 3 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 1 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Data from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 4 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 2 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 8 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 5 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 6 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Data from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 7 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 8 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 1 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 4 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
Supplementary Figure 6 from 3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers
2023Open Access
page 1 of 19Next →

Frequent Co-authors

Zuo‐Feng Zhang(12), Valerie B. O’Donnell(5), Matthew N. Hodgkin(5), Trevor R. Pettitt(5), Friedrich Spener(4), Edward A. Dennis(4), Barrie Peck(4), Adrian L. Harris(4), Almut Schulze(4), Ashley Martin(4), Shankar Subramaniam(3), Robert C. Murphy(3), Gerhard Liebisch(3), Harald Köfeler(3), Elizabeth A. Smethurst(3), Fredrik Karpe(3), Miles D. Houslay(3), Dale Powner(3), Eoin Fahy(2), Martin Trötzmüller(2)